Tonix Pharmaceuticals TNXP
11.8
0.44
3.87
%
即將開盤
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 32.98 | 140 | -20.68 | -22 | -17.15 | 163 |
| 2024Q3 | 14.85 | 74 | -24.44 | -14 | -17.20 | 95 |
| 2024Q2 | 69.74 | 42 | -104.86 | -79 | -76.61 | 70 |
| 2024Q1 | 595.20 | 108 | -13.98 | -15 | -10.31 | 135 |
| 2023Q4 | 1289.60 | 106 | -24.14 | -27 | -18.60 | 154 |
| 2023Q3 | 1744.00 | 121 | -21.41 | -28 | -18.71 | 139 |
| 2023Q2 | 5056.00 | 140 | -18.54 | -28 | -16.74 | 160 |
| 2023Q1 | 11822.00 | 165 | -17.72 | -33 | -16.31 | 179 |
| 2022Q4 | 7796.00 | 207 | -14.53 | -32 | -13.53 | 226 |
| 2022Q3 | 10684.00 | 229 | -12.68 | -29 | -11.17 | 243 |
| 2022Q2 | 31600.00 | 228 | -10.61 | -23 | -9.26 | 276 |
| 2022Q1 | 147328.00 | 208 | -12.38 | -26 | -11.37 | 224 |
| 2021Q4 | 228928.00 | 219 | -14.04 | -30 | -12.97 | 241 |
| 2021Q3 | 384704.00 | 202 | -9.68 | -19 | -9.17 | 215 |
| 2021Q2 | 710400.00 | 180 | -13.18 | -24 | -12.64 | 189 |
| 2021Q1 | 819200.00 | 177 | -15.61 | -21 | -14.66 | 184 |
| 2020Q4 | 432000.00 | 88 | -22.66 | -17 | -20.53 | 98 |
| 2020Q3 | 537600.00 | 63 | -20.65 | -12 | -19.04 | 68 |
| 2020Q2 | 390720.00 | 54 | -33.43 | -14 | -30.73 | 58 |
| 2020Q1 | 454400.00 | 31 | -35.77 | -7 | -30.00 | 34 |
